Novel Schizophrenia Treatments Target Glutamate Receptors

Brain circuit problem likely sets stage for the "voices" that are symptom of schizophrenia
Brain circuit problem likely sets stage for the “voices” that are symptom of schizophrenia
Many new agents in development target receptors of the neurotransmitter glutamate.

A paradigm shift in schizophrenia treatment is focusing on the glutamate system for new agents to address all symptom domains. Learn what adjunctive agents are in development to treat negative and cognitive symptoms as well as agents that work through different pathways.

READ FULL ARTICLE Curated publisher From http://www.cmeinstitute.com/psychlopedia/psychosis/9mbs/sec6/section.asp